Compound 178
Identifiers
- Canonical SMILES:
CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2)[C@]11C(=O)Nc2cc(Cl)ccc12)C(=O)NCC[C@H](O)CO
- IUPAC name:
(2'R,3S,3'R,5'R)-6-chloro-3'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C27H33Cl2N3O4/c1-26(2,3)13-21-27(19-8-7-17(29)12-20(19)31-25(27)36)22(15-5-4-6-16(28)11-15)23(32-21)24(35)30-10-9-18(34)14-33/h4-8,11-12,18,21-23,32-34H,9-10,13-14H2,1-3H3,(H,30,35)(H,31,36)/t18-,21+,22-,23+,27+/m0/s1
- InChiKey:
NAOQNYFVXDLIDP-OKWRDYKUSA-N
External links
168318325 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 8.40 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 533.18 g/mol | |||
HBA | 7 | |||
HBD | 5 | |||
HBA + HBD | 12 | |||
AlogP | 3.27 | |||
TPSA | 110.69 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19928922 | 6 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 7.25 | |
19928922 | 6 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.40 | |
19928922 | 6 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.22 |
19928922 | 6 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | Saos-2 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.54 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8750 | SAR-405838 | DB12541 | |
0.6919 | Milademetan | DB15257 | |
0.5680 | Degarelix | DB06699 | |
0.5667 | SLV-334 | DB15356 | |
0.5600 | Mosapramine | DB13676 | |
0.5484 | Daglutril | DB05796 | |
0.5479 | Acyline | DB11906 | |
0.5449 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07090 | |
0.5449 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07222 | |
0.5417 | Abarelix | DB00106 | |
0.5337 | OPC-51803 | DB05838 | |
0.5281 | Brimapitide | DB15231 | |
0.5227 | Benazeprilat | DB14125 | |
0.5198 | Prajmaline | DB13555 | |
0.5198 | Ajmaline | DB01426 |